Complex Regional Pain Syndrome (CRPS) is a chronic pain condition that usually affects an arm or leg. It causes intense pain that is out of proportion to any inciting event. Symptoms also frequently involve changes in skin color or texture, changes in skin temperature, swelling, or profuse sweating in the affected area. Advance therapies such as drugs, physical therapy, psychotherapy and nerve blocks help in managing the condition effectively.
The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 103.07 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: Adoption of advanced therapies is one of the major trends being witnessed in the complex regional pain syndrome market. Drugs such as NSAIDs, antidepressants, anticonvulsants and bisphosphonates are commonly prescribed to relieve pain associated with CRPS. Additionally, therapies such as sympathetic nerve blocks, spinal cord stimulators implants, physical & occupational therapy and psychotherapy are also gaining popularity due to better management of the condition. Growing awareness about these treatment options and favorable reimbursement policies are contributing to the increased adoption of advanced therapies for complex regional pain syndrome. This in turn is expected to drive the market growth over the forecast period.
Segment Analysis
The global complex regional pain syndrome market is dominated by the non-opioid analgesic segment, which accounts for over 30% share. Non-opioid analgesics are preferred first line treatments for CRPS due to their effectiveness and relatively mild side effects. With growing awareness about adverse effects of opioid drugs, the demand and sales of non-opioid analgesics is expected to rise significantly over the forecast period.
Key Takeaways
The global Complex Regional Pain Syndrome Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to grow at a CAGR of 7.2% during this period and reach a size of US$ 103.07 Mn by 2024.
Regional analysis: North America currently dominates the global CRPS market and is expected to continue its dominance through the forecast period. The region accounts for over 40% share of the global market due to high disease prevalence and growing awareness among people and healthcare providers regarding the available treatment options. Asia Pacific region is expected to be the fastest growing market owing to rising healthcare expenditure and increasing patient pool in developing countries such as China and India.
Key players operating in the complex regional pain syndrome market are Intercos S.p.A., Kolmar Korea Co. Ltd., Scalpi Cosmética sa, Cosmax Inc., Mana Products Inc., KBL cosmetics Ltd., Urist Cosmetics Incorporated, Fareva Holding SA, Milliona Cosmetics Co., Ltd., Skinlys, Maesa SAS, Schwanhäußer Holding GmbH & Co. KG, Tricorbraun Inc., Herrco Cosmetics Limited, Architectural Beauty, Allure Labs Inc., Case Mason Filling, Inc., Pardaco Trading Pte Ltd, and KDC/ONE among others.
Explore more related article on this topic: https://www.newsanalyticspro.com/complex-regional-pain-syndrome-market-is-driven-by-rising-prevalence/
https://www.shayaricenter.com/artificial-kidney-a-solution-to-end-stage-kidney-disease
